Dashboard
Manage Tickers

IMRN Immuron Ltd

Nasdaq immuron.com.au


$ 2.00 $ 0.10 (5.26 %)    

Monday, 03-Nov-2025 17:11:27 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 624.27 $ 0.00 (0 %)
DIA $ 470.61 $ 0.00 (0 %)
SPY $ 676.95 $ 0.00 (0 %)
TLT $ 89.85 $ 0.00 (0 %)
GLD $ 366.68 $ 0.00 (0 %)
$ 2
$ 1.90
$ 1.82 x 261
$ 1.99 x 134
-- - --
$ 1.50 - $ 2.48
31,355
na
11.4M
$ 0.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
11/03/2025 12:05:47

immuron-completes-minor-protocol-updates-for-imm-529-ind-following-fda-request-for-additional-clinical-information
Immuron Completes Minor Protocol Updates F...
10/31/2025 10:05:11

IMM-529 IND: currently under review, FDA request for Information – minor updates to clinical protocol completed and submitted T...

immuron-reported-q1-sales-growth-of-34-on-prior-comparative-period
Immuron Reported Q1 Sales Growth Of 34% On...
10/13/2025 10:07:01

Sales Highlights (unaudited):Global• Q1 sales AUD$2.0 million up 34% on prior comparative period (pcp)Australia • Q1 sales AUD$...

immuron-submits-ind-to-fda-for-oral-imm-529-targeting-clostridioides-difficile-with-phase-2-trial-planned-in-h1-2026-for-cdi-treatment-and-rcdi-prevention
Immuron Submits IND To FDA For Oral IMM-52...
10/08/2025 10:17:45

immuron-says-it-is-on-track-to-exceed-fy24-first-quarter-sales-to-request-end-of-phase-2-meeting-with-fda-for-imm-124e
Immuron Says It Is On Track To Exceed FY24...
10/02/2025 10:38:08

US Tariffs: Immuron does not anticipate any material impact from the recently announced US tariffs on pharmaceutical productsTr...

immuron-advances-fda-filings-and-preps-2025-launch-of-new-ibs-treatment-proibs-eyes-october-results-for-travelan-us-military-trial
Immuron Advances FDA Filings And Preps 202...
10/02/2025 10:08:06

Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to p...

reported-earlier-immuron-partners-with-investorhub-to-launch-interactive-investor-hub-enhancing-shareholder-communication-and-engagement
Reported Earlier, Immuron Partners With In...
08/27/2025 05:56:34

why-interactive-brokers-group-shares-are-trading-higher-by-5-here-are-20-stocks-moving-premarket
Why Interactive Brokers Group Shares Are T...
07/18/2025 10:34:38

immuron-says-2025-sales-growth-of-49-for-travelan-exceeded-projection
Immuron Says 2025 Sales Growth Of 49% For ...
07/17/2025 10:07:21

GlobalAnnual sales AUD$7.3 million up 49% on prior yearJune 2025 Quarter AUD$2.0 million up 55% on prior yearAustralia Annual s...

immuron-projects-a7m-sales-eyes-travelan-study-results-and-ind-filing-in-2025
Immuron Projects A$7M Sales, Eyes Travelan...
05/30/2025 10:30:04

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/21/2025 12:07:32

reported-earlier-immurons-travelan-hits-record-aud53m-in-ytd-sales-up-46-yoy-and-86-in-north-america
Reported Earlier, Immuron's Travelan Hits ...
04/11/2025 05:45:41

GlobalImmuron exceeds AUD$5 million in sales in a fiscal year - highest sales in historyMarch 2025 Quarter AUD$1.3 million up 2...

immuron-announced-it-has-entered-into-an-exclusive-distribution-agreement-for-the-territories-of-australia-and-new-zealand
Immuron Announced It Has Entered Into An E...
03/05/2025 11:01:09

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/17/2025 21:05:47

immuron-says-global-sales-for-december-2024-quarter-totals-aud25m-up-70-on-prior-quarter
Immuron Says Global Sales For December 202...
01/17/2025 11:04:53

Sales of Travelan increased 90% to AUD $1.851 million during December 2024 Quarter compared to AUD $1.007 million for September...

immuron-enters-new-research-collaboration-with-monash-university
Immuron Enters New Research Collaboration ...
01/15/2025 11:01:18

After the results from this research agreement are known, the parties will negotiate in good faith (and without obligation) whe...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/14/2025 12:05:34

immuron-submits-phase-2-study-report-to-fda-prepares-for-end-of-phase-2-meeting-takes-next-step-toward-phase-3-trial
Immuron Submits Phase 2 Study Report to FD...
01/14/2025 11:06:27

Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to a...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/29/2024 12:08:00

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/29/2024 12:07:59

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION